Price has finally got down to where I think I'll take a little nibble. The news about CBI starting construction on a LNG train was the catalyst. May be up and down for awhile: this is a long term holding. Good Luck!
Dear Kittnibbly: The holders of the company's debt will get the assets. You are right in noting that management doesn't want that to happen, either. Will they be able to avoid bankruptcy? Stay tuned.
I am very afraid that we are heading for the pink sheets and bankruptcy--I have lost the equivalent of two of my family's cars on this gamble. They had money from the sale to that VC firm--Ihopeihopeihope they husband it carefully enough to survive.
Because the lower dose is working, would be one reason. FDA wants to ramp up slowly, ARWR wanted to get to the finish line ASAP. Calm down everybody! A clinical hold for signs of toxicity would be reason to sell, but we don't seem to have that (yet). Keep calm and carry on, the companies prospects are as bright as ever.
I hope that they might license ARC520 for an upfront chunk'o change and good solid royalties. GILD only wants the liver aspect? ARWR will want to keep the platform for the myriad other diseases it can address.